SCHEMBL17599397

SCHEMBL17599397

Cc1c(S(=O)(=O)Nc2ccc(-c3cc(C(=O)O)ccc3F)c3ccccc23)cnn1CC(C)C

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 7/20 0.44
PTK2B Q14289 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ACLY P53396 3/20 0.41
RAD52 P43351 1/20 0.39
PKM P14618 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
FABP5 Q01469 3/20 0.39
TDP1 Q9NUW8 1/20 0.38
ERAP2 Q6P179 2/20 0.37
ERAP1 Q9NZ08 2/20 0.37
SLC16A3 O15427 1/20 0.37
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599355 0.89 PTK2B (0.43) FABP4PTK2BSMN1; SMN2ACLYRAD52
SCHEMBL17599365 0.86 TDP1 (0.41) FABP4ACLYRAD52TDP1ERAP2
SCHEMBL17599392 0.84 CCKBR (0.47) FABP4PTK2BSMN1; SMN2ACLYRAD52
SCHEMBL17599311 0.81 PTK2B (0.43) FABP4PTK2BSMN1; SMN2ACLYRAD52
SCHEMBL17599399 0.76 PTK2B (0.57) FABP4PTK2BSMN1; SMN2ACLYFABP5
SCHEMBL17599385 0.76 TSHR (0.47) FABP4PTK2BSMN1; SMN2ACLYRAD52
SCHEMBL17599333 0.76 PTK2B (0.52) FABP4PTK2BSMN1; SMN2ACLYRAD52
SCHEMBL17599412 0.76 FABP4 (0.45) FABP4PTK2BSMN1; SMN2ACLYFABP5
SCHEMBL17599320 0.75 SMN1; SMN2 (0.54) FABP4PTK2BSMN1; SMN2ACLYTDP1
SCHEMBL17599391 0.75 FABP4 (0.61) FABP4ACLYRAD52TDP1ERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed